Data indicate that introducing IL-7 into B7-H3 CAR-7 cells (B7-H3 CAR-7/IL-7), may effectively kill CMA cells in the organoid model and exhibit sustained anti-tumor effects (Wu et al., 2024a). This evidence concerns the gene CD276 and neoplasm.